Lakeland Industries Inc. (LAKE) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$8.88 -1.11% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $8.85

Lakeland Industries Inc. (LAKE) carries a Roarable Rating of D- (Sell) with 38/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- β€’ RED ALERT Cap $88.2M
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on LAKE Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is LAKE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-01, Lakeland Industries Inc. (NASDAQ: LAKE) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $8.88 (-1.11% 1D, market cap $88.2M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, LAKE ranks #719 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does LAKE compare to CNXU and NTRB in the Health Care sector?
β–Ό

Within the Health Care sector (Industrial Specialties), LAKE carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 32.9%, and ROIC of -9.5%. By comparison, CNXU (Conexeu Sciences Inc.) holds a D+ grade (56/100 RQD, P/E N/A, ROIC β€”, cap $85.8M) and NTRB (Nutriband Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $80.7M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for LAKE?
β–Ό

Per LAKE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-31, CIK 0000798081), Lakeland Industries Inc. generated $192.6M in revenue (+15.2% YoY), -$25.3M in net income, and -$16.4M in free cash flow against $209.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $8.85 (-0.39%)🧬 Dilution Drag (+2.48% YoY Shares)βš™οΈ Cash Engine: 7/20 (D-) β€’ 0% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record Warning: Scores below 50 (38/100 Β· D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.8% avg 90D alpha vs SPY β€’ 29.0% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERRED ALERT β€’ D-
025507510038
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E Β· Rk D
Cash (7)Whales (8)SEC (10)Macro (10)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-9% Base Target
$18 Bull$8 Base$6 Bear
πŸ“¬ FREE LAKE RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for LAKE)Realized 20D OHLCV Swing Band: Β±12.5%
Deterministic 5-Pillar Attribution (38/100 Composite)
πŸ” WHY LAKE SCORES 38/100 (D-) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (26% of score)

Altman Z-Score 2.04 (WATCH ZONE (1.8–3.0)) β€’ Piotroski F-Score 4/9

β–² #2 Bullish Driver: Macro Regime Fit+10/20 pts (26% of score)

FRED Regime Γ— Technicals: 18% of 52W Range β€’ RSI-14 at 36 (NEUTRAL RANGE)

β–Ό #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
46
Grade D$9.96-8.7% Next Q
Q2 (-2Q)
43
Grade D$9.09+5.5% Next Q
Q3 (-1Q)
41
Grade D$9.59-7.4% Next Q
Current
38
Grade D-$8.88-7.8% Hist 90D Ξ±
Trajectory: D (46) β†’ D- (38)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a LAKE Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While LAKE currently carries a cautious 38/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($10.37) and Max Pain ($9.32) forces dealer call-delta covering toward $17.76.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $LAKEβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œLAKE Beats Next Quarter EPS Consensus (Jan 30, 2027) & Holds Above 200D SMA”
VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL β€’ FY 2025 (10-K)

How LAKE Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$0 (0% FCF Margin)
Revenue$192.6MGross Profit $63.3M (32.9%)Cost of Sales $129.3MOp Profit $0 (0%)OpEx (R&D/SG&A) $63.3MNet Profit$0 (0%)Tax/Other $0

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

β–  Revenueβ–  Net Profitβ–  Free Cash Flow
FY23
Rev $124.7M
FY24
Rev $167.2M
FY25
Rev $192.6M
Fiscal YearRevenueGross MarginOp MarginNet ProfitFree Cash FlowROIC %
FY 2025$192.6M32.9%-8.1%-$25.3M-$16.4M-9.5%
FY 2024$167.2M41.1%-5.5%-$18.1M-$17.4M-5%
FY 2023$124.7M32.9%4.8%$5.4M$10.9M-9.5%
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring LAKE)

  • βœ“Walkthrough of LAKE's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
LAKE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -12.68%πŸ›‘οΈ HOLDING TREND SUPPORT
2026-10-30O $8.82H $8.95L $8.55C $8.88VOL 178.5K
RES: $12.03SUP: $8.64SMA50: $10.37SMA200: $10.14
$12.99$11.79$10.58$9.38$8.18RES $12.03SUP $8.64$8.882026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

LAKE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +15.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on LAKE today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for LAKE. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for LAKE today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (LAKE)

1. Head-to-Head Health Care Peer Comparison (LAKE vs. CNXU, NTRB, AGPU, APT)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Lakeland Industries Inc. (LAKE) ranks #719 by composite RQD confidence (38/100, grade D-) and #678 by equity capitalization ($88.2M). Within this direct 5-issuer industry benchmark cohort, APT leads on earnings valuation at 16.2x trailing P/E, while APT leads on capital efficiency and profitability with 6.7% ROIC and 38.1% gross margin. APT currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with LAKE at 38/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
LAKE ACTIVE
Lakeland Industries Inc.
D- 38/100 β€” 32.9% -9.5% -1.11% $88.2M Benchmark Subject
CNXU
Conexeu Sciences Inc.
D+ 56/100 β€” β€” β€” -1.74% $85.8M /cnxu-vs-lake β†’
NTRB
Nutriband Inc.
D- 40/100 β€” 27.8% -35.0% +3.75% $80.7M /ntrb-vs-lake β†’
AGPU
Axe Compute Inc.
D- 37/100 β€” β€” -35.0% -2.01% $101.7M /agpu-vs-lake β†’
APT
Alpha Pro Tech Ltd.
D+ 58/100 16.2x 38.1% 6.7% +1.28% $56.6M /apt-vs-lake β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2026-01-31 β€’ CIK 0000798081

In its most recent audited fiscal period (FY2025, filed 2026-01-31), Lakeland Industries Inc. (LAKE) reported GAAP revenue of $192.6M (+15.2% vs. FY2024 revenue of $167.2M , and +54.5% cumulative change since FY2023) , GAAP net income of -$25.3M, operating cash flow of -$15.8M, and free cash flow of -$16.4M (+5.7% YoY). On the balance sheet, LAKE closed FY2025 with $209.9M in total assets against $0 in total debt (Altman Z-Score: 2.04, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2026-01-31 $192.6M -$25.3M -$15.8M -$16.4M $209.9M β€”
FY2024 (FY) 2025-01-31 $167.2M -$18.1M -$15.9M -$17.4M $212.5M β€”
FY2023 (FY) 2024-01-31 $124.7M $5.4M $10.9M $10.9M β€” β€”

3. LAKE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is LAKE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Lakeland Industries Inc. (NASDAQ: LAKE) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $8.88 (-1.11% 1D, market cap $88.2M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, LAKE ranks #719 in composite RQD confidence.

How does LAKE compare to CNXU and NTRB in the Health Care sector?

Within the Health Care sector (Industrial Specialties), LAKE carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 32.9%, and ROIC of -9.5%. By comparison, CNXU (Conexeu Sciences Inc.) holds a D+ grade (56/100 RQD, P/E N/A, ROIC β€”, cap $85.8M) and NTRB (Nutriband Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $80.7M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for LAKE?

Per LAKE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-31, CIK 0000798081), Lakeland Industries Inc. generated $192.6M in revenue (+15.2% YoY), -$25.3M in net income, and -$16.4M in free cash flow against $209.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is LAKE trading relative to its 50-day, 200-day, and 52-week technical levels?

LAKE last traded at $8.88 (-1.11% on volume of 77,583 shares), positioning the stock -14.37% below its 50-day simple moving average ($10.37) and -12.43% below its 200-day simple moving average ($10.14). Across its 52-week range of $7.15 to $16.91, LAKE sits at the 17.7% percentile with a 14-day RSI of 36.0 (NEUTRAL RANGE) and an implied next-earnings move of Β±12.5% ($7.77 to $9.99).

LAKE Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

How profitable is Lakeland Industries Inc. (LAKE)?

In FY 2025 (10-K), LAKE converted $192.6M of revenue into a 32.9% gross margin, 0% operating margin, and $0 in free cash flow (0% FCF margin).

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%